25 results on '"Goossens, Julie"'
Search Results
2. Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
3. Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer’s disease and a history of traumatic brain injury
4. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
5. Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
6. Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders
7. P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
8. Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer’s disease; relation to cognition, atrophy and synaptic density.
9. Differential Expression of Synaptic Biomarkers in the Cerebrospinal Fluid Differentiates Behavioural Variant of Frontotemporal Dementia from Primary Psychiatric Disorders and Alzheimer’s Disease
10. Two novel beta synuclein specific assays for the detection of Alzheimer’s disease
11. Combination of cerebrospinal fluid VAMP-2 and core AD biomarkers reflects episodic memory deficits in sporadic Alzheimer’s disease
12. Large-scale cerebrospinal fluid proteomic analysis in Alzheimer's disease patients reveals five molecular subtypes with distinct genetic risk profiles.
13. Additional file 1 of Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
14. Development of a Nanobody-based lateral flow assay to detect active Trypanosoma congolense infections
15. VAMP2 is a cerebrospinal fluid marker of selective hippocampal synapse loss and episodic memory performance in Alzheimer’s disease
16. Exploring molecular biomarkers with potential prognostic value in longitudinal observational studies on Alzheimer’s disease
17. Quantifying the synaptic vesicle‐associated protein, VAMP2, to verify changes in cerebrospinal fluid in preclinical stages of Alzheimer’s disease
18. An Unbiased Immunization Strategy Results in the Identification of Enolase as a Potential Marker for Nanobody-Based Detection of Trypanosoma evansi
19. Structural and kinetic characterization of Trypanosoma congolense pyruvate kinase
20. Development of a recombinase polymerase amplification lateral flow assay for the detection of active Trypanosoma evansi infections
21. Corrigendum to “DNA detection of Trypanosoma evansi: Diagnostic validity of a new assay based on loop-mediated isothermal amplification (LAMP)” [Vet. Parasitol. 250 (2018) 1–6]
22. DNA detection of Trypanosoma evansi: Diagnostic validity of a new assay based on loop-mediated isothermal amplification (LAMP)
23. Functionalization of gold nanoparticles with nanobodies through physical adsorption
24. Boosting In Planta Production of Antigens Derived from the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Subsequent Evaluation of Their Immunogenicity
25. Boosting In Planta Production of Antigens Derived from the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Subsequent Evaluation of Their Immunogenicity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.